DUALITAS Trademark

Trademark Overview

On Wednesday, February 8, 2023, a trademark application was filed for DUALITAS with the United States Patent and Trademark Office. The USPTO has given the DUALITAS trademark a serial number of 97786301. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, April 8, 2025. This trademark is owned by Dualitas Therapeutics, Inc.. The DUALITAS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields; Providing medical and scientific research information in the pharmaceutical and biotechnology fields; Research and development services in the field of antibodies; none of the foregoing relating to holograms or holographic technology
dualitas

General Information

Serial Number97786301
Word MarkDUALITAS
Filing DateWednesday, February 8, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, April 8, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 8, 2025

Trademark Statements

Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields; Providing medical and scientific research information in the pharmaceutical and biotechnology fields; Research and development services in the field of antibodies; none of the foregoing relating to holograms or holographic technology

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 27, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDualitas Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameDualitas Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Wednesday, August 9, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Saturday, February 11, 2023NEW APPLICATION ENTERED
Monday, February 27, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 6, 2023ASSIGNED TO EXAMINER
Thursday, November 9, 2023NON-FINAL ACTION WRITTEN
Thursday, November 9, 2023NON-FINAL ACTION E-MAILED
Thursday, November 9, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 14, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 14, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 14, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 20, 2023ASSIGNED TO EXAMINER
Wednesday, November 20, 2024ASSIGNED TO EXAMINER
Monday, December 16, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, February 19, 2025ASSIGNED TO EXAMINER
Wednesday, January 10, 2024SUSPENSION LETTER WRITTEN
Wednesday, January 10, 2024LETTER OF SUSPENSION E-MAILED
Wednesday, January 10, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, March 13, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 13, 2025TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, March 13, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 14, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 14, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 14, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, March 14, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 14, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 2, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 8, 2025PUBLISHED FOR OPPOSITION
Tuesday, April 8, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords

dualitas research fields biotechnology pharmaceutical development relating foregoing technology none holographic